The results of our investigation showed a strong relationship between the expression of SMARCAL1 and several immune checkpoint genes, including CD276, NRP1, TNFSF4, CD40, CD200, and CD80 in Glioma, LUAD, LIHC, KIRC, and UCEC. Here, CD276 is linked to central nervous system cancer.